Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Ocugen reports promising interim results for OCU410 clinical trial in geographic atrophy Ocugen, Inc. has taken a significant step forward in the fight against geographic atrophy (GA) secondary to dry… byPallavi MadhirajuDecember 19, 2024